Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Bromadiolone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01616
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Bromadiolone inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
Coumatetralyl |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01617
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Coumatetralyl inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde inhibits the expression of DME VKORC1L1 |
[2] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME VKORC1L1 |
[2] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Phenprocoumon |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00206
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Phenprocoumon inhibits the drug-metabolizing activity of DME VKORC1L1 |
[3] |
Acenocoumarol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00513
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Acenocoumarol inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
Fluindione |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00471
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Fluindione inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME VKORC1L1 |
[4] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
4-hydroxycoumarin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00866
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
4-hydroxycoumarin inhibits the drug-metabolizing activity of DME VKORC1L1 |
[1] |
|
|
|
|
|
|